《新股表現》樂思(02540.HK)半日收1.42元 高上市價29%
樂思集團(02540.HK)今早(8日)首日掛牌,股價低開18%報0.9元獲承接,掉頭向上,最高見1.5元,半日收1.42元,較上市價1.1元,高32仙或29%,半日成交5,250萬股,涉資6,464萬元。
樂思是內地移動廣告服務供應商。是次來港上市共發售1.25億股,其中10%公開發售獲21.35倍超購,已啟動回撥機制佔比增至30%,人人有份;股份以招股範圍(1.1至1.5元)下限定價,料集資淨額8,473萬元,主要用於擴充在內地移動廣告業務、擴大短視頻製作能力、優化和升級自家開發平台功能,以及尋求與具規模公司業務合作及併購機會等。上市獨家保薦人華升資本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.